Aura Biosciences, Inc. (AURA)
Nasdaq: AURA · Biological Products, (No Diagnostic Substances) · Boston, MA · filing with the SEC since 2010
Who runs Aura Biosciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Holles Natalie C.
Chief Executive Officer and President. First filing May 2026, latest May 19, 2026, 0 filings in all.
Officers reporting now
10
of 15 people with a filing in the last fifteen months
Directors reporting now
5
22 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Abu-Absi Susan | Chief Operating Officer | Aug 2026 | Sep 1, 2026 | none |
| Hopkins Janet Jill | Chief Medical Officer | Oct 2023 | Sep 1, 2026 | 2 · $200,000 |
| Kratz Erica | Chief Reg. & Quality Officer | Aug 2026 | Sep 1, 2026 | none |
| Person Julie | Chief People Officer | Aug 2026 | Sep 1, 2026 | none |
| Elazzouzi Amy | SVP, Finance & PAO | Oct 2024 | Sep 1, 2026 | 3 · $100,000 |
| Kilroy Conor | Chief Legal Officer and Secretary | Apr 2024 | Jul 1, 2026 | 2 · $100,000 |
| Gibney Anthony S | Chief Financial and Business Officer. | May 2025 | Jun 16, 2026 | 1 · $100,000 |
| Holles Natalie C. | Chief Executive Officer and President | May 2026 | May 19, 2026 | none |
| De Los Pinos Elisabet | President and Chief Executive Officer | Oct 2021 | Mar 3, 2026 | 3 · $400,000 |
| Plavsic Mark | Chief Technology Officer | Mar 2024 | Mar 3, 2026 | 2 · $200,000 |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bender Jeremy | director | Jul 2026 | Jul 8, 2026 | none |
| Bitetti Teresa Marie | director | Mar 2025 | Jun 15, 2026 | none |
| Johnson David Michael | director | Oct 2021 | Jun 15, 2026 | none |
| Mattessich Antony C. | director | Oct 2021 | Jun 15, 2026 | none |
| Srivastava Sapna | director | Oct 2021 | Jun 15, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Goel David E. | 10% owner | Oct 2021 | May 11, 2026 | none |
| Matrix Capital Management Company, LP | 10% owner | Oct 2021 | May 11, 2026 | 1 · $39.0M |
Earlier names on the record11, newest filing first
Feder Julie B · officer · last filing Oct 2024Parekh Rajesh B · director · last filing Jun 2023De Rosch Mark · officer · last filing Jan 2023Rich Cadmus · officer · last filing Jan 2023Medicxi Growth Co-Invest I LP · 10% owner · last filing Nov 2021Medicxi Growth I Gp Ltd · 10% owner · last filing Nov 2021Medicxi Growth I LP · 10% owner · last filing Nov 2021Medicxi Ventures Management (Jersey) Ltd · 10% owner · last filing Nov 2021Primiano Christopher Brett · officer · last filing Oct 2021Mariggi Giovanni · director · last filing Oct 2021Takhar Karan S. · director · last filing Oct 2021
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.